According to filings with the U.S. Securities and Exchange Commission, Candid Health has raised $120 Million in new Series D funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

Investors in the company’s current round of funding include: Sixth Street Growth, Oak HC/FT, 8VC, Y Combinator

About Candid Health
Candid Health is a healthcare technology company that provides a revenue cycle automation platform designed to help modern healthcare organizations automate and optimize their end-to-end revenue cycle and medical billing operations. Its software focuses on making complex medical billing easier by integrating with existing healthcare technology stacks and reducing the amount of engineering and operational effort required to manage revenue cycle management (RCM) processes. The company positions itself as a leader in autonomous revenue cycle management, using advanced automation to improve financial outcomes for providers by decreasing the cost to collect and increasing net collection rates. Candid Healths platform is marketed to innovative, tech-forward healthcare providers who want robust, efficient, and intelligent infrastructure for RCM so they can focus more on delivering high-quality, affordable, and accessible care. The company has grown significantly, joining Y Combinator in 2020, raising multiple funding rounds including a $120M Series D to fuel autonomous RCM, and earning industry recognition such as Best RCM Software and financial-solution innovation awards, signaling its strong market position in healthcare revenue cycle automation.

To learn more, visit https://candidhealth.com/
Linkedin: https://www.linkedin.com/company/candid-health

Contact:
Nick Perry, Chief Executive Officer
https://www.linkedin.com/in/nick-perry-36b0364/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.